News
Dry eye is very common, especially post corneal refractive surgery, and should be treated preoperatively with attention paid ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
PulseSight Technologies recently announced the successful dosing of the first patient in the phase I clinical trial ...
Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
The trial will evaluate the safety and tolerability of Tinlarebant and its potential to reduce atrophic lesion growth rate in ...
In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
The VISTA trial is evaluating and comparing 2 dose levels of laru-zova with an untreated control group for the treatment of X ...
Healthcare professionals must stop supplying the affected batch, quarantine stock, and return it to suppliers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results